FindTrial
Sign In

The application of Analgesia Nociception Index guided Remifentanil administration during general anesthesia for Spinal Surgery

The application of Analgesia Nociception Index guided Remifentanil administration during general anesthesia for Spinal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003639
Enrollment
Unknown
Registered
2013-09-07
Start date
2012-09-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar spinal stenosis and/or lumbar intervertebral disc herniation

Interventions

ANI group:ANI guide the administration of remifentanil
control group:remifentanil was adapted by Anaesthesiologist corresponding to clinical experiences

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: ASA status I-II, aged 18-70 years, BMI 17-33kg.m-2, scheduled for elective posterior lumbar decompression and internal fixation for treatment of lumbar canal stenosis and/or lumbar disc herniation.

Exclusion criteria

Exclusion criteria: pregnancy, non sinus rhythms, ANS altering diseases or medications, allergy to drugs used in this study ,baseline hemodynamic index that would be considered as abnormal(such as SBP>160mmHg or SBP90min-1or HR<45 min-1).

Design outcomes

Primary

MeasureTime frame
total number of unwanted events;the consumption of anesthetics;—

Countries

China

Contacts

Public ContactLiping Zhang

Department of Anesthesia, Third Hospital, Peking University

lipingzhang01@aliyun.com+86 13911113805

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026